Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Inflammatory Bowel Diseases

  Free Subscription


11.03.2024

1 AJR Am J Roentgenol
3 Aliment Pharmacol Ther
1 Am J Gastroenterol
1 BMC Gastroenterol
3 Clin Gastroenterol Hepatol
1 Dig Dis Sci
4 Dis Colon Rectum
2 Gastroenterol Hepatol
1 Gastroenterology
8 Inflamm Bowel Dis
6 J Crohns Colitis
1 Lancet
3 PLoS One
1 Scand J Gastroenterol


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AJR Am J Roentgenol


  1. Correction for: "ADC Values for Detecting Bowel Inflammation and Biologic Therapy Response in Patients With Crohn Disease: A Post Hoc Prospective Trial Analysis".
    AJR Am J Roentgenol. 2024;222:e2430951.
    PubMed        


    Aliment Pharmacol Ther

  2. GARCIA MJ, Riestra S, Amiot A, Julsgaard M, et al
    Effectiveness and safety of a third-line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study).
    Aliment Pharmacol Ther. 2024 Mar 6. doi: 10.1111/apt.17938.
    PubMed         Abstract available

  3. LU C, Rosentreter R, Delisle M, White M, et al
    Systematic review: Defining, diagnosing and monitoring small bowel strictures in Crohn's disease on intestinal ultrasound.
    Aliment Pharmacol Ther. 2024 Mar 4. doi: 10.1111/apt.17918.
    PubMed         Abstract available

  4. BOKEMEYER B, Plachta-Danielzik S, Steiner IM, Pohlschneider D, et al
    Inflammatory bowel disease (IBD) patients with impaired quality of life on biologic therapy benefit from the support of an IBD nurse specialist: Results of a randomised controlled trial in Germany (IBD(BIO-ASSIST) study).
    Aliment Pharmacol Ther. 2024 Mar 1. doi: 10.1111/apt.17926.
    PubMed         Abstract available


    Am J Gastroenterol

  5. EBACH DR, Jester TW, Galanko JA, Firestine AM, et al
    High Body Mass Index and Response to Anti-TNF Therapy in Pediatric Crohn Disease.
    Am J Gastroenterol. 2024 Mar 6. doi: 10.14309/ajg.0000000000002741.
    PubMed         Abstract available


    BMC Gastroenterol

  6. HU N, Liu J, Gao X, Tang H, et al
    The association between hemoglobin level and sarcopenia in Chinese patients with Crohn's disease.
    BMC Gastroenterol. 2024;24:95.
    PubMed         Abstract available


    Clin Gastroenterol Hepatol

  7. NARULA N, Wong ECL, Dulai PS, Patel J, et al
    Defining Endoscopic Remission in Crohn's Disease: MM-SES-CD and SES-CD Thresholds Associated with Low Risk of Disease Progression.
    Clin Gastroenterol Hepatol. 2024 Feb 28:S1542-3565(24)00212.
    PubMed         Abstract available

  8. WIJNANDS AM, Penning de Vries BBL, Lutgens MWMD, Bakhshi Z, et al
    Dynamic prediction of advanced colorectal neoplasia in inflammatory bowel disease.
    Clin Gastroenterol Hepatol. 2024 Feb 29:S1542-3565(24)00214.
    PubMed         Abstract available

  9. AXELRAD JE, Rubin DT
    The Management of Colorectal Neoplasia in Patients With Inflammatory Bowel Disease.
    Clin Gastroenterol Hepatol. 2024 Feb 29:S1542-3565(24)00108.
    PubMed        


    Dig Dis Sci

  10. OLIVEIRA R, Martins V, de Sousa HT, Roseira J, et al
    Food-Related Quality of Life and Its Predictors in Inflammatory Bowel Disease.
    Dig Dis Sci. 2024 Mar 8. doi: 10.1007/s10620-024-08333.
    PubMed         Abstract available


    Dis Colon Rectum

  11. SPINELLI A
    Expert Commentary on Ileoanal Pouch Construction for Inflammatory Bowel Disease.
    Dis Colon Rectum. 2024 Mar 5. doi: 10.1097/DCR.0000000000003330.
    PubMed        

  12. OBI M, Holubar SD
    Ileoanal Pouch Construction for Inflammatory Bowel Disease.
    Dis Colon Rectum. 2024 Mar 5. doi: 10.1097/DCR.0000000000003329.
    PubMed        

  13. PARASCANDOLA SA, McChesney SL, Khan A
    Construction of an Endoluminal Vacuum Using Readily Available Supplies for the Management of Leak After IPAA.
    Dis Colon Rectum. 2024;67:e248-e249.
    PubMed        

  14. RAM E, Zager Y, Carter D, Saukhat O, et al
    A Prospective, Single-Arm Study to Evaluate the Safety and Efficacy of an Autologous Blood Clot Product in the Treatment of Anal Fistula.
    Dis Colon Rectum. 2024;67:541-548.
    PubMed         Abstract available


    Gastroenterol Hepatol

  15. NAVARRO-GERRARD C, Calafat M, Benitez JM, Suarez-Ferrer C, et al
    Are biologic agents effective and safe in patients with IBD and solid organ transplantation?
    Gastroenterol Hepatol. 2024;47:289-292.
    PubMed        

  16. LASA J, Smolarczuk A, Navar S, Ponce C, et al
    Endoscopic scoring system utilization for inflammatory bowel disease activity assessment: A multicenter real-world study from Argentina.
    Gastroenterol Hepatol. 2024;47:253-261.
    PubMed         Abstract available


    Gastroenterology

  17. MITEV S, Marinova C, Spassova Z
    A colorful conundrum: dark urine in a patient with inflammatory bowel disease.
    Gastroenterology. 2024 Mar 5:S0016-5085(24)00249.
    PubMed        


    Inflamm Bowel Dis

  18. FAMUTIMI D, Alayo QA, Deepak P
    Reply to: Beyond Discrimination: A Call for Comprehensive Assessment of Clinical Prediction Models in Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2024 Mar 8:izae049. doi: 10.1093.
    PubMed        

  19. GEESALA R, Zhang K, Lin YM, Johnson JC, et al
    Exclusive Enteral Nutrition Alleviates Th17-Mediated Inflammation via Eliminating Mechanical Stress-Induced Th17-Polarizing Cytokines in Crohn's-like Colitis.
    Inflamm Bowel Dis. 2024;30:429-440.
    PubMed         Abstract available

  20. TSE CS, Hunt MG, Brown LA, Lewis JD, et al
    Inflammatory Bowel Diseases-related Disability: Risk Factors, Outcomes, and Interventions.
    Inflamm Bowel Dis. 2024;30:501-507.
    PubMed         Abstract available

  21. HESAMPOUR F, Bernstein CN, Ghia JE
    Brain-Gut Axis: Invasive and Noninvasive Vagus Nerve Stimulation, Limitations, and Potential Therapeutic Approaches.
    Inflamm Bowel Dis. 2024;30:482-495.
    PubMed         Abstract available

  22. D'AMICO F, Peyrin-Biroulet L, Danese S
    Disease Clearance is not Synonymous with Cure.
    Inflamm Bowel Dis. 2024;30:509.
    PubMed        

  23. HOXHA T, Youssef M, Huang V, Tandon P, et al
    Inflammatory Bowel Disease and Breastfeeding: A Narrative Review.
    Inflamm Bowel Dis. 2024 Mar 4:izae033. doi: 10.1093.
    PubMed         Abstract available

  24. GEERTSEMA S, Fagundes RR, Otten AT, Dijkstra G, et al
    Interleukin-18 Inhibition in Inflammatory Bowel Disease: A Delicate Balance.
    Inflamm Bowel Dis. 2024 Mar 5:izae042. doi: 10.1093.
    PubMed        

  25. PILLAY L, Subramanian S
    The Long View: 2-Year Outcomes of Mirikizumab for Ulcerative Colitis.
    Inflamm Bowel Dis. 2024 Mar 7:izae025. doi: 10.1093.
    PubMed        


    J Crohns Colitis

  26. ELLRICHMANN M, Schulte B, Conrad CC, Schoch S, et al
    Contrast enhanced endoscopic ultrasound detects early therapy response following anti-TNF-therapy in patients with ulcerative colitis.
    J Crohns Colitis. 2024 Mar 8:jjae034. doi: 10.1093.
    PubMed         Abstract available

  27. TEUGELS A, van den Eijnden I, Keersmaekers B, Verstockt B, et al
    Disease acceptance, but not perceived control, is uniquely associated with inflammatory bowel disease-related disability.
    J Crohns Colitis. 2024 Mar 6:jjae025. doi: 10.1093.
    PubMed         Abstract available

  28. BIEL C, Faber KN, Bank RA, Olinga P, et al
    Matrix metalloproteinases in intestinal fibrosis.
    J Crohns Colitis. 2024;18:462-478.
    PubMed         Abstract available

  29. WARSOP ZI, Manzo CA, Yu N, Yusuf B, et al
    Patient-reported Outcome Measures in Ileoanal Pouch Surgery: a Systematic Review.
    J Crohns Colitis. 2024;18:479-487.
    PubMed         Abstract available

  30. JOJART B, Resal T, Kata D, Molnar T, et al
    Plasminogen Activator Inhibitor 1 Is a Novel Faecal Biomarker for Monitoring Disease Activity and Therapeutic Response in Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:392-405.
    PubMed         Abstract available

  31. WEBER S, Sitte S, Voegele AL, Sologub L, et al
    NLRP3 Inhibition Leads to Impaired Mucosal Fibroblast Function in Patients with Inflammatory Bowel Diseases.
    J Crohns Colitis. 2024;18:446-461.
    PubMed         Abstract available


    Lancet

  32. DOLINGER M, Torres J, Vermeire S
    Crohn's disease.
    Lancet. 2024 Mar 1:S0140-6736(23)02586-2. doi: 10.1016/S0140-6736(23)02586.
    PubMed         Abstract available


    PLoS One

  33. FU C, Wang Q, Chen Y, Zhang Y, et al
    Exploring the causal relationship between airborne particulate matter and ulcerative colitis: A two-sample mendelian randomization study.
    PLoS One. 2024;19:e0300066.
    PubMed         Abstract available

  34. RIDSDALE K, Khurana K, Taslim AT, Robinson JK, et al
    Quality improvement exercises in Inflammatory Bowel Disease (IBD) services: A scoping review.
    PLoS One. 2024;19:e0298374.
    PubMed         Abstract available

  35. WANG Z, Nie J, Song X, Denson LA, et al
    A comparison of Bayesian and frequentist approaches to incorporating clinical and biological information for the prediction of response to standardized pediatric colitis therapy.
    PLoS One. 2024;19:e0295814.
    PubMed         Abstract available


    Scand J Gastroenterol

  36. MERTZ NIELSEN A, Theede K, Gluud LL, Kiszka-Kanowitz M, et al
    Efficacy of optimised thiopurine therapy in patients with moderate-to-severe ulcerative colitis: retrospective long-term follow-up from two randomised trials.
    Scand J Gastroenterol. 2024 Mar 5:1-5. doi: 10.1080/00365521.2024.2323502.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Inflammatory Bowel Diseases is free of charge.